Fennec Pharmaceuticals (FENC) Non Operating Income (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Non Operating Income came in at -$2.1 million in Q4 2025, down 210.06% YoY from $1.9 million in Q4 2024, and down 373.72% on a QoQ basis from -$449000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Non Operating Income (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Non Operating Income data on file, last reported at -$2.1 million in Q4 2025.
- Quarterly Non Operating Income fell 210.06% year-over-year to -$2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.4 million (down 27.06% YoY) and the FY2025 annual result came in at -$3.4 million, down 27.06% from the prior year.
- Non Operating Income declined to -$2.1 million in Q4 2025, from -$449000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $190000.0 in Q1 2021 to a low of -$2.1 million in Q4 2025.
- A 5-year average of -$525700.0 and a median of -$481500.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income soared 2011.11% — and 2022, when it plunged 1483.33%.
- Tracing FENC's Non Operating Income over 5 years: stood at -$220000.0 in 2021, then tumbled by 228.18% to -$722000.0 in 2022, then slipped by 19.67% to -$864000.0 in 2023, then rose by 20.6% to -$686000.0 in 2024, then plunged by 210.06% to -$2.1 million in 2025.
- The last three Non Operating Income figures came in at -$2.1 million (Q4 2025), -$449000.0 (Q3 2025), and -$420000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 278,000.00 |
| Dec 31, 2025 | -2.13 Mn |
| Sep 30, 2025 | -449,000.00 |
| Jun 30, 2025 | -420,000.00 |
| Mar 31, 2025 | -357,000.00 |
| Dec 31, 2024 | -686,000.00 |
| Sep 30, 2024 | -533,000.00 |
| Jun 30, 2024 | -514,000.00 |
| Mar 31, 2024 | -906,000.00 |
| Dec 31, 2023 | -864,000.00 |
| Sep 30, 2023 | -850,000.00 |
| Jun 30, 2023 | -778,000.00 |
| Mar 31, 2023 | -782,000.00 |
| Dec 31, 2022 | -722,000.00 |
| Sep 30, 2022 | -190,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Dec 31, 2021 | -220,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -81,000.00 |